ENO1 and breast carcinoma: In breast cancer, increased levels of cell surface ENO-1 correlated with enhanced migration and invasion of cancer cells and these effects where abrogated by a specific peptide blocking PLG binding to ENO-1 (Didiasova et al., 2015).